Expressive arts intervention for adults with vision loss due to aging
Unlocking Limitations Through Arts: A Mixed Methods Study on the Effectiveness of an Expressive Arts-based Intervention on Psychosocial Wellbeing of Adults With Age-related Visual Impairment
NA · The University of Hong Kong · NCT05675150
This study is testing a creative arts program to see if it can help adults aged 50 to 80 with vision loss from aging feel better and adjust to their changes in sight.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 154 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | The University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT05675150 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a multimodal, expressive arts-based intervention designed for adults aged 50 to 80 with age-related macular degeneration (AMD). The intervention aims to enhance psychosocial wellness and help participants adjust to gradual vision loss through creative engagement. Participants will be randomly assigned to either the expressive arts intervention group or a treatment-as-usual control group over an 8-week period. The study will assess various outcomes, including psychosocial adaptation, quality of life, and symptoms of depression and anxiety.
Who should consider this trial
Good fit: Ideal candidates are Chinese-speaking adults aged 50 to 80 diagnosed with age-related macular degeneration.
Not a fit: Patients who are totally blind or have significant comorbidities that impair their ability to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the psychosocial well-being and quality of life for patients with age-related macular degeneration.
How similar studies have performed: While expressive arts interventions have shown promise in other populations, this specific approach for AMD is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants are community-dwelling, Chinese-speaking adults aged between 50 and 80, with the diagnosis of age-related macular degeneration in one or both eyes of all different etiologies Exclusion Criteria: * Inability to understand the Chinese language, as well as a diagnosis of total blindness, presence of other significant physical, psychological, and cognitive comorbidities that would hinder the participant from completing the study will be excluded.
Where this trial is running
Hong Kong
- Centre on Behavioral Health, The University of Hong Kong — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Rainbow Ho — Director/Professor
- Study coordinator: Rainbow Ho
- Email: tinho@hku.hk
- Phone: (852)28315158
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Age-Related Macular Degeneration, Age-related visual impairment, Psychosocial wellbeing, Expressive arts-based intervention, Macular degeneration, Randomized controlled trial